Amir Sada Khan

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Cornelia L. Trimble, Matthew P. Morrow, Kimberly A. Kraynyak et al. · The Lancet · 2015 · 689 citations

Immunology, Human Papillomavirus 16, Cancer-associated Virus +17

Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses

Mark L. Bagarazzi, Jian Yan, Matthew P. Morrow et al. · Science Translational Medicine · 2012 · 279 citations · Full text

Mangosteen peel waste as a sustainable precursor for high surface area mesoporous activated carbon: Characterization and application for methylene blue removal

Asma Nasrullah, Bahruddin Saad, A.H. Bhat et al. · Journal of Cleaner Production · 2018 · 250 citations

Chemical Engineering, High Surface Area, Engineering +14

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

Kar Muthumani, Darryl Falzarano, Emma L. Reuschel et al. · Science Translational Medicine · 2015 · 249 citations · Full text

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Spyros A. Kalams, Scott Parker, Marnie Elizaga et al. · The Journal of Infectious Diseases · 2013 · 193 citations · Full text